Production of pathogenic antibodies such as the RF is quite relevant to the development of RA (10), and its inhibition is another piece of evidence for the large spectrum of tolerance achieved by Hsp65-lac treatment in arthritis. This evidence concerns the gene HSPD1 and rheumatoid arthritis.